XML 49 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
Investments in Other Entities (Tables)
 12 Months Ended
Dec. 31, 2021
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Equity Method Investments, Financial Statement Information
Investments in other entities – equity method consisted of the following (in thousands):
December 31, 2020
Initial InvestmentAllocation of Income (Loss)ContributionSaleConsolidation of Entity
December 31, 2021
LaSalle Medical Associates – IPA Line of Business$13,047 $— $(5,831)$— $(4,182)$— $3,034 
Pacific Medical Imaging & Oncology Center, Inc.1,413 — 306 — — — 1,719 
Diagnostic Medical Group2,613 — 330 — — (2,943)— 
531 W. College, LLC – related party17,200 — (208)238 — — 17,230 
One MSO, LLC — related party2,395 — 515 — — — 2,910 
Tag-6 Medical Investment Group, LLC — related party4,516 — 314 — — — 4,830 
Tag-8 Medical Investment Group, LLC — related party2,108 — — 1,660 — (3,768)— 
CAIPA MSO, LLC— 11,724 268 — — — 11,992 
$43,292 $11,724 $(4,306)$1,898 $(4,182)$(6,711)$41,715 
LMA’s unaudited summarized balance sheets at December 31, 2021 and 2020 and unaudited summarized statements of operations for the years ended December 31, 2021, 2020, and 2019 are as follows (in thousands):
Balance Sheets
December 31, 2021
(unaudited)		December 31, 2020
(unaudited)
Assets
Cash and cash equivalents$6,619 $9,350 
Receivables, net2,269 3,918 
Other current assets— 881 
Loan receivable2,250 2,250 
Restricted cash696 691 
Total assets$11,834 $17,090 
Liabilities and stockholders’ deficit
Current liabilities$32,405 $21,589 
Stockholders’ deficit
(20,571)(4,499)
Total liabilities and stockholders’ deficit
$11,834 $17,090 
Statements of Operations
Year Ended
December 31, 2021
(unaudited)		Year Ended
December 31, 2020
(unaudited)		Year Ended
December 31, 2019
(unaudited)
Revenues$204,061 $186,964 $194,020 
Expenses220,132 185,724 205,153 
Income (loss) from operations(16,071)1,240 (11,133)
Other income— 8 — 
Net income (loss)$(16,071)$1,248 $(11,133)